Biotech News
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
ir.fatetherapeutics.com2026-05-06 14:57 EST
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases,